The FDA has issued a warning letter to Wellmill LLC, doing business as Vitamix Laboratories in Nesconset, NY, after inspectors found significant violations of federal Juice HACCP requirements — including an inadequate hazard analysis and the absence of a required pathogen-reduction process.

For juice processors, the warning letter carries direct regulatory weight. FDA's juice safety rule requires every processor to perform a hazard analysis and implement a Critical Control Point system that applies a validated 5-log pathogen reduction treatment. Inspectors concluded Vitamix Laboratories failed on both fronts.

What does the warning letter require?

Under FDA enforcement procedure, the company has 15 days to respond to the warning letter. The letter itself typically arrives only after FDA has given a firm months — sometimes years — to correct documented problems, which signals that earlier compliance efforts fell short.

The specific violations cited include:

• Significant violations of the Juice Hazard Analysis and Critical Control Point regulations
• An inadequate hazard analysis
• Failure to apply a required pathogen-reduction process to juice products

FDA warning letters are part of the agency's routine enforcement activities and apply to entities under its jurisdiction. Some letters are not posted for public view until weeks or months after they are sent, and portions are often redacted before publication.

Why this matters for juice operators

The Juice HACCP rule is a cornerstone of FDA's juice safety framework, and pathogen-reduction failures sit at its center. Processors that cannot document an adequate hazard analysis and a validated kill step expose themselves not only to enforcement escalation but to recall and liability risk downstream.

Whether Vitamix Laboratories corrects its HACCP documentation and implements the required pathogen-reduction treatment within the response window — or faces further FDA action — will determine the next chapter of this enforcement case.